Shenzhen Weiguang Biological Products Co Ltd Class A 002880
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 29.31
- Day Range
- CNY 29.22–29.60
- 52-Week Range
- CNY 22.05–42.18
- Bid/Ask
- CNY 29.56 / CNY 29.57
- Market Cap
- CNY 6.71 Bil
- Volume/Avg
- 492,796 / 1.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 33.02
- Price/Sales
- 6.23
- Dividend Yield (Trailing)
- 0.68%
- Dividend Yield (Forward)
- 0.68%
- Total Yield
- 0.68%
Company Profile
Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 796
- Website
- http://www.szwg.com
Comparables
Valuation
|
Metric
|
002880
|
300601
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.02 | 36.88 | 40.79 |
Price/Book Value | 3.22 | 2.11 | 2.29 |
Price/Sales | 6.23 | 6.32 | 5.51 |
Price/Cash Flow | 19.84 | 24.26 | 25.02 |
Price/Earnings
002880
300601
300142
Financial Strength
|
Metric
|
002880
|
300601
|
300142
|
|---|---|---|---|
Quick Ratio | 2.14 | 1.47 | 2.46 |
Current Ratio | 6.42 | 2.15 | 2.85 |
Interest Coverage | 22.89 | 2.18 | 47.19 |
Quick Ratio
002880
300601
300142
Profitability
|
Metric
|
002880
|
300601
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | 7.55% | 3.75% | 3.37% |
Return on Equity (Normalized) | 10.65% | 5.79% | 5.57% |
Return on Invested Capital (Normalized) | 8.73% | 4.61% | 3.91% |
Return on Assets
002880
300601
300142
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Mnxvglbhm | Ywpbsk | $78.4 Bil | |
ZTS
| Zoetis Inc Class A | Cjbhbbqzy | Fqsd | $77.9 Bil | |
HLN
| Haleon PLC ADR | Xyqmbmhq | Hcmr | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Whvrnkgcn | Rsdfl | $18.8 Bil | |
VTRS
| Viatris Inc | Gymkcxsr | Hlr | $12.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ftlfvmz | Xdhn | $12.0 Bil | |
CTLT
| Catalent Inc | Vptnnsggz | Pljplk | $9.7 Bil | |
PRGO
| Perrigo Co PLC | Xzpbynjk | Lrlf | $3.7 Bil | |
CURLF
| Curaleaf Holdings Inc | Qkhrkvk | Xnflk | $3.4 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bjxyrjsng | Njnvx | $3.1 Bil |